![Luke Walker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luke Walker
Direktor/Vorstandsmitglied bei
ZENTALIS PHARMACEUTICALS, INC.
Vermögen: 805 536 $ am 31.05.2026
Profil
Dr. Luke N.
Walker, MD, is a Chief Medical Officer at Umoja Biopharma, Inc., an Independent Director at Context Therapeutics, Inc. and an Independent Director at Zentalis Pharmaceuticals, Inc. He is on the Board of Directors at Context Therapeutics, Inc. and Zentalis Pharmaceuticals, Inc. Dr. Walker was previously employed as a Chief Medical Officer by Harpoon Therapeutics, Inc., a Vice President-Clinical Development by Seagen, Inc., and a Vice President-Clinical Development by CASCADIAN THERAPEUTICS INC.
He received his doctorate degree from the University of Oklahoma College of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.06.2026 | 201.384 ( 0,28 % ) | 805 536 $ | 31.05.2026 | |
| 24.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Luke Walker
| Unternehmen | Position | Beginn |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 29.05.2024 |
| CONTEXT THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 04.09.2024 |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2025 |
Ehemalige bekannte Positionen von Luke Walker
| Unternehmen | Position | Ende |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2024 |
| SEAGEN INC. | Corporate Officer/Principal | 01.10.2022 |
| CASCADIAN THERAPEUTICS INC (USA) | Technik-/Wissenschafts-/F&E-Leiter | 09.03.2018 |
Ausbildung von Luke Walker
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
10
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Oklahoma College of Medicine
 University of Oklahoma College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Wählen Sie MarketScreener 
